1. Home
  2. GRDX vs CLPS Comparison

GRDX vs CLPS Comparison

Compare GRDX & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

HOLD

Current Price

$3.22

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Logo CLPS Incorporation

CLPS

CLPS Incorporation

N/A

Current Price

$0.94

Market Cap

28.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GRDX
CLPS
Founded
N/A
2005
Country
United Kingdom
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
33.2M
28.3M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
GRDX
CLPS
Price
$3.22
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 147.2K
13.6K
Earning Date
11-16-2026
10-16-2026
Dividend Yield
N/A
★ 15.37%
EPS Growth
★ 21.95
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$0.80
52 Week High
$6.93
$1.24

Technical Indicators

Market Signals
Indicator
GRDX
CLPS
Relative Strength Index (RSI) 36.24 41.75
Support Level $3.23 N/A
Resistance Level $4.19 $0.99
Average True Range (ATR) 0.79 0.08
MACD -0.26 -0.01
Stochastic Oscillator 26.36 15.79

Price Performance

Historical Comparison
GRDX
CLPS

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

About CLPS CLPS Incorporation

CLPS Inc is information technology, consulting and solutions service provider, focused on delivering services mainly to world-wide institutions, including banking, wealth management, ecommerce, and automotive areas both in China and globally. It has been at the forefront of driving digital transformation and optimizing operational efficiency across industries through innovations in artificial intelligence (AI), cloud computing, and data. It diverse business lines span sectors including fintech, payment and credit services, e-commerce, education and study abroad programs, and world-wide tourism integrated with transportation services. Its segments are IT services and academic education service. Majority of revenue comes from IT services segment. Its products are NiBot RPA, and CAKU.

Share on Social Networks: